Do you want to read an article? Please log in or register.
Unplanned Hospitalization Due to All-Cause Morbidity and Its Real-World Management Practices in Patients With Fontan Circulation
Further Publications
Related content
Heart Failure
Impact of glp-1 receptor agonists on hospitalization for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study
Clin Res Cardiol
Ojeda-Fernández L, Torrigiani G, Molteni M, Fortino I, Cimminiello C, Baviera M
doi: 10.1007/s00392-025-02674-9
RECOMMENDED
Further Publications
Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Atherosclerosis
Galimberti F, Capra ME, Olmastroni E, Braghiroli D, Banderali G, Baratta F, Biasucci G, Biolo M, Buonuomo PS, Cefalù AB, Cipollone F, Citroni N, D'Addato S, Genovesi S, Guardamagna O, Iughetti L, Mandraffino G, Minicocci I, Mombelli GG, Montalcini T, Nascimbeni F, Passaro A, Pirro M, Rinaldi E, Sbrana F, Scicali R, Suppressa P, Werba PJ, Zenti MG, Arca M, Averna M, Tarugi P, Calandra S, Catapano AL, Pederiva C, Casula M, LIPIGEN Paediatric Group
doi: 10.1016/j.atherosclerosis.2026.120691
Hypertension
Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)
Drugs Real World Outcomes
Escribano Subias P, Chakinala MM, Chin KM, Didden EM, Doad G, Farber HW, Gaine S, Hemnes AR, Highland KB, Lange TJ, McLaughlin V, Muller A, Rahman M, Remeňová T, Söderberg S, Venkatesh A, Kim NH
doi: 10.1007/s40801-025-00536-4
Heart Failure
Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure
Circulation
Berg DD, Patel SM, Haller PM, Cange AL, Palazzolo MG, Bellavia A, Kuder JF, Desai AS, Inzucchi SE, McMurray JJV, O'Meara E, Verma S, Bělohlávek J, Drożdż J, Merkely B, Ogunniyi MO, Drasnar T, Izzo JL, Sarman B, McGinty JE, Ramanathan K, Mulkay AJ, Przybylski A, Ruff CT, O'Donoghue ML, Murphy SA, Sabatine MS, Wiviott SD, DAPA ACT HF-TIMI 68 Trial Committees and Investigators
doi: 10.1161/CIRCULATIONAHA.125.076575
Heart Failure
Predicting Heart Failure Outcomes Using Patient-Reported Health Status: Real-World Validation of the KCCQ-12
J Am Coll Cardiol
El-Sabawi BR, Al-Garadi MA, Steitz BD, Perkins AM, McCoy AB, Sengstack DG, Greevy RA Jr, Burnell EH, Schlendorf KH, Lindenfeld J, Stevenson LW, Gupta DK, Spertus JA, Collins SP, Matheny ME, Bachmann JM
doi: 10.1016/j.jacc.2025.03.545
Heart Failure
Prognostic Impact of Cardiovascular-Kidney-Metabolic Overlap Among Patients With Acute Heart Failure: Insights From a Real-World Multinational Cohort
J Am Heart Assoc
Marchetti M, Antiochos P, Pitta-Gros B, Abdurashidova T, Soborun N, Monney P, Yerly P, Tzimas G, Skalidis I, Vollenweider P, Gencer B, Fakhouri F, Vaduganathan M, Hullin R, Lu H
doi: 10.1161/JAHA.125.045294
Atrial FibrillationFurther Publications
Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis
Circ Arrhythm Electrophysiol
Venier S, Defaye P, Lochon L, Benali R, Bisson A, Carabelli A, Diouf Y, Jacon P, Fauchier L
doi: 10.1161/CIRCEP.125.014101
Myocardial Infarction
Progression to type 2 diabetes among post-myocardial infarction patients with overweight or obesity: a real-world cohort study
Cardiovasc Diabetol
Tonnesen PT, Olesen KKW, Gyldenkerne C, Hansen MK, Stødkilde-Jørgensen N, Thrane PG, Andersen MH, Poulsen PL, Thomsen RW, Sattar N, Sørensen HT, Maeng M
doi: 10.1186/s12933-026-03085-4
Heart, Artery and Coronary Diseases
Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study
Atherosclerosis
Wu JY, Chang HY, Kao CL, Hung KC, Yu T, Lin YM
doi: 10.1016/j.atherosclerosis.2025.120390